You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Universal Attenuated Malaria Sporozoite Vaccine and Challenge System
SBC: SANARIA INC. Topic: N/ADESCRIPTION (provided by applicant): / Abstract Malaria causes 500 million clinical cases & 1-3 million deaths/yr, is responsible for > 1% loss of GDP in Africa/yr, and is a serious concern for travelers. When attenuated P. falciparum sporozoites (PfSPZ) are administered by bite of infected mosquitoes > 90% of humans are protected against experimental Pf challenge and protection lasts at least 10. ...
SBIR Phase II 2006 Department of Health and Human ServicesNational Institutes of Health -
Cortical Health Index Monitor (CHI)
SBC: INFINITE BIOMEDICAL TECHNOLOGIES, LLC Topic: N/ADESCRIPTION (provided by applicant): Cardiac arrest claims over 450,000 lives per year in the United States alone. There is a high incidence of neurological complications amongst survivors, and these represent the leading cause of morbidity. Over the past several years, the care of these patients has been improved via the introduction of new systemic as well as neurospecific therapies. Speed of in ...
SBIR Phase II 2006 Department of Health and Human ServicesNational Institutes of Health -
Optoacoustic imaging enhanced by gold nanorods
SBC: FAIRWAY MEDICAL TECHNOLOGIES, INC. Topic: N/ADESCRIPTION (provided by applicant): The main objective of this project is to develop a contrast agent to allow noninvasive imaging and monitoring of breast cancer with molecular specificity. The basis of the proposed method is a combination of optoacoustic imaging, nanotechnology and molecular biology of cancer. Laser Optoacoustic Imaging System (LOIS) uses near-infrared laser pulses to genera ...
SBIR Phase II 2006 Department of Health and Human ServicesNational Institutes of Health -
Reliable and Robust ECG Gating Signal for Cardiac MR Imaging
SBC: PERINATRONICS MEDICAL SYSTEMS, INC. Topic: N/ADESCRIPTION (provided by applicant): Magnetic Resonance Imaging (MRI) has become the gold standard for the quantitative assessment of cardiac structure and function. The key to imaging the moving myocardium is a reliable and robust electrocardiogram signal which, used as a "trigger," can provide images at specified phases throughout the cardiac cycle. Stronger field strength magnets, greater magne ...
SBIR Phase II 2006 Department of Health and Human ServicesNational Institutes of Health -
Automated Seizure Detection Following Nerve Agent Exposure
SBC: INFINITE BIOMEDICAL TECHNOLOGIES, LLC Topic: N/ADESCRIPTION (provided by applicant): Seizures following a nerve agent (NA) attack induce a time-critical emergency which can lead to sudden death or severe morbidity. Survival is dependent upon early and aggressive therapy. Seizures may not be evident from physical examination, and emergency personnel typically cannot interpret the electroencephalogram. Thus, as noted in the RFA, there is a pressi ...
SBIR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health -
DNA Vaccine Delivery System for Biodefense with dengue
SBC: CYTO PULSE SCIENCES, INC. Topic: N/ADESCRIPTION (provided by applicant): The long-term objective is the commercialization of a safe, effective, easy to use and painless polynucleotide vaccine delivery system that can be used in vaccines for biodefense against NIAID Category A, B and C pathogens. In addition to biodefense related vaccines, the Easy Vax vaccine delivery system which is the subject of this commercialization project can ...
SBIR Phase II 2006 Department of Health and Human ServicesNational Institutes of Health -
Software for Accurate Ligand-Protein Affinities
SBC: VERACHEM LLC Topic: N/ADESCRIPTION (provided by applicant): Discovering a compound that will bind a protein therapeutic target with high affinity, while retaining favorable pharmacological properties, can be a time-consuming and expensive bottleneck in the drug-discovery process. Computational methods can speed this ligand discovery step, but are not yet reliable enough to circumvent extensive experimental testing, even ...
SBIR Phase II 2006 Department of Health and Human ServicesNational Institutes of Health -
Surgical navigation system for in-bore MRI-guided breast interventions
SBC: ROBIN MEDICAL INC Topic: N/ADESCRIPTION (provided by applicant): The project long-term objective is to develop a surgical navigational system that will enable in-bore, MR imaging guided interventions on any type of scanner. This new system will facilitate the use of MRI to guide diagnostic and therapeutic interventions. MRI has unique advantages compared with other imaging modalities? It has exceptional high soft-tissue cont ...
SBIR Phase II 2006 Department of Health and Human ServicesNational Institutes of Health -
Sensitive, Integrating Multi-Waveguide Biosensor
SBC: CREATV MICROTECH INC Topic: N/ADESCRIPTION (provided by applicant): Chronic lymphocytic leukemia (CLL) is a heterogeneous disease. Many patients never need treatment, whereas others have an aggressive clinical outcome with significantly reduced median survival. New treatments that can induce complete remission permit patients with poor outlook to be treated while they are still asymptomatic. However, asymptomatic patients with ...
SBIR Phase II 2006 Department of Health and Human ServicesNational Institutes of Health -
Development of Superactive Analogs of FSH
SBC: TROPHOGEN INC Topic: N/ADESCRIPTION (provided by applicant): Infertility affects about 10% of American couples, and there is a very large and rapidly growing market for therapeutics in this field, particularly the primary hormone responsible for ovarian oocyte development, follicle-stimulating hormone (FSH). Although available urinary and recombinant FSH products have been quite successful, there is currently an unmet th ...
SBIR Phase II 2006 Department of Health and Human ServicesNational Institutes of Health